Craig Crews

Yale Professor, Founder of @ArvinasInc, Halda Therapeutics, @[email protected]

[Craig Crews @CraigMCrews]

Chemical Biology Comes of Age- it's been great to shepherd our academic chemical biology idea from concept to the clinic over the past twenty years. My hopes have long been for #PROTACs to have a clinical benefit for patients. Good luck @Arvinas! https://t.co/ILhi6vfySD

[Craig Crews @CraigMCrews]

X’s dominance ‘over’ as Bluesky becomes new hub for research https://t.co/yNGY6bxWUM via @timeshighered

[Craig Crews @CraigMCrews]

https://t.co/BhqE50HRND

[Stuart Cantrill @stuartcantrill]

This will be my last post here; vast majority of tweets should be deleted in the next two weeks or so. Will then protect the account and just occasionally pop over to check #ContaminatedBlood news. It was fun while it lasted. Find me at https://t.co/oYQV23Sayo

[Craig Crews @CraigMCrews]

How Bluesky, Alternative to X and Facebook, Is Handling Explosive Growth https://t.co/HnERTDkfYa

[Craig Crews @CraigMCrews]

How to migrate from X to Bluesky without losing your followers https://t.co/YomSQuGkgE via @ZDNET & @jperlow

[PCMag @PCMag]

X saw record traffic after Election Day, but 115,000 people still hit the delete button. X's loss is Bluesky's gain; the site just topped the 15 million user mark, up from 9 million in September. https://t.co/hoA6IMxxg8

[Stephen King @StephenKing]

I'm leaving Twitter. Tried to stay, but the atmosphere has just become too toxic. Follow me on Threads, if you like.

[Roux Lab @RouxLab]

Following the wave of scientific labs migrating to bluesky, we will soon close this account, please follow us on @rouxlab.bsky.social.

[Frances Arnold @francesarnold]

You can find me on Bluesky @bluesky at https://t.co/YSq7jUIzz5
I hope to see you there!

[Craig Crews @CraigMCrews]

Bluesky might end up defeating Twitter once and for all https://t.co/sevJpF3hBb via @slate

[Craig Crews @CraigMCrews]

Bluesky might end up defeating Twitter once and for all https://t.co/sevJpF3hBb via @slate

[Craig Crews @CraigMCrews]

@craigmcrews.bsky.social

[Craig Crews @CraigMCrews]

@craigmcrews.bsky.social

[Craig Crews @CraigMCrews]

@impression_ists Wow! Cool!

[Yale Cancer Center @YaleCancer]

Congratulations to @CraigMCrews, elected to the 2024 Class of Fellows of the @AACR Academy.
Read more: https://t.co/j5FnGDsy2I
@SmilowCancer @YaleMed @YNHH @MCDB_Yale

[Gianluca Sbardella @g_sbardella]

@CraigMCrews is the awardee of the 2024 IUPAC-Richter Prize (@IUPAC @_GedeonRichter)! The acceptance lecture will be held in Rome, Italy (Sept. 1-5, 2024) at the #EFMCISMC24 (https://t.co/0SJpNzRNIq). What an addition to an already amazing program!
@EuroMedChem @DCFSCI

[ACS Biochem and ChemBio @acsbiol]

Congratulations to @CraigMCrews on receiving the Kimberly Prize from @NUFeinbergMed for pioneering studies of #PROTACs in the lab and their translation to clinical trials! Read more here: https://t.co/irihro1vlk

[Milka Kostić, PhD @MilkaKostic]

Targeted Protein Degradation gets a nod from the Gabbay Award in Biotechnology and Medicine, a one-of-a-kind award administered by @BrandeisU that recognizes practical applications in biomedical sciences - congratulations to Ray Deshaies, and @CraigMCrews
https://t.co/bSRZ2vzBjk

[Dan Nomura @DanNomura]

Grateful to see our work highlighted alongside leaders in the field @craigmcrews @IngridWertz @ChoudharyLab @SchreiberStuart in the exciting and exploding area of proximity-inducing modalities for drug discovery in @NatRevDrugDisc https://t.co/2hbqtNqPkH

[Craig Crews @CraigMCrews]

Ever try to drug an oncoprotein driver only to have the tumor lose its dependency on it and become drug resistant? Introducing RIPTACs (Regulated Induced Proximity Targeting Chimeras) in collaboration with Halda Therapeutics.